NextPhase Therapeutics
- Carlos Paya
Carlos Paya is a board member of two publicly listed companies (NYSE and NASDAQ). He was President and CEO, Immune Design Corp, until its acquisition by Merck.
Org chart
This person is not in the org chart
NextPhase Therapeutics
Carlos Paya is a board member of two publicly listed companies (NYSE and NASDAQ). He was President and CEO, Immune Design Corp, until its acquisition by Merck.
This person is not in the org chart
